For an update on the status of CADTH’s Therapeutic Review of Third-Line Drugs for Type 2 Diabetes, please visit our news section. CADTH undertook a project to assess the clinical and cost...

Multiple myeloma (MM) is a hematological cancer that mainly affects individuals older than 65 years of age. Though MM remains incurable, several life-prolonging pharmacotherapies for the treatment of...